C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
COVID-19에서 항균 관리를 위한 C 반응성 단백질 및 프로칼시토닌
Original Paper
[키워드] Admission
Analysis
Antibiotic therapy
antimicrobial resistance
Antimicrobial stewardship
AUC
Bacterial infection
Bacterial infections
best
C-reactive protein
C-reactive protein (CRP
calculated
caused
characteristic
Clinical course
coronavirus disease
Coronavirus disease 2019
Course
COVID-19
COVID-19 pneumonia
CRP
CRP level
CRP levels
cut-off value
differentiation
elevated
entire cohort
evaluated
focus
had no
help
highest
Hospital stay
Hospitalization
ICU
Infection
Inpatient
Laboratory
Lower respiratory tract
lower respiratory tract infections
majority
on admission
pandemic
Patient
patients with COVID-19
PCT
performed
physician
Pneumonia
Prevent
procalcitonin
receiver operating characteristic
respiratory
Respiratory Coronavirus
Respiratory tract infections
Result
Retrospective study
ROC
ROC analysis
SARS-CoV-2
secondary bacterial infection
Secondary bacterial infections
Secondary infection
sensitivity
Sensitivity and specificity
severe acute respiratory coronavirus
severe acute respiratory coronavirus 2
specificity
Spread
the disease
therapy
Viral
with COVID-19
[DOI] 10.1007/s15010-021-01615-8 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.1007/s15010-021-01615-8 PMC 바로가기 [Article Type] Original Paper